Emerging Therapeutic Options in Pancreatic Cancer Management.

Published in: International journal of molecular sciences (2024)

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a 5-year survival rate of <8% [...].

Keyphrases